proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix)

April 2009

There's growing concern that proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix).

At first many experts dismissed this because it was based on in vitro platelet aggregation studies...not clinical outcomes.

Now some new studies suggest that patients taking clopidogrel plus a PPI actually have more cardiovascular events.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote